You have no items in your shopping cart.

GE in India: Changing Healthcare
Malodia, Suresh; Jaiswal, Anand Kumar Case IIMA-MAR0476 / Published January 7, 2016 / 24 pages. Collection: Indian Institute of Management, Ahmedabad
Format Price Quantity Select
PDF Download
$6.95
Printed Black & White Copy
$7.25

Product Overview

GE Healthcare was on a continuous lookout for investing into new and innovative super value products for the Bottom of the Pyramid markets in India. After launching its first successful super value ECG machine Mac 400, GE had recently launched its twenty-fifth super value product a PET CT machine. Serving the BOP markets has its own unique challenges that may be different for each product that is placed in the market. However, GE has so far successfully sailed through all the challenges and developed a steep learning curve about BOP markets. However, it is now facing the challenge of ensuring sustainability of product pipeline. The company is also keen to exploit the opportunities for reverse innovation that super value products have provided. The company also wants to assess the disruptive impact of these products in domestic medical device markets as well as markets outside India.



Learning Objectives

To enable discussions on the potential opportunity that the BoP market has in the healthcare and strategies to exploit this opportunity. To understand the complexity involved in entering the BoP markets. To examine how reverse innovations can be a source of sustainable strategic advantage for MNCs.


  • Videos List

  • Overview

    GE Healthcare was on a continuous lookout for investing into new and innovative super value products for the Bottom of the Pyramid markets in India. After launching its first successful super value ECG machine Mac 400, GE had recently launched its twenty-fifth super value product a PET CT machine. Serving the BOP markets has its own unique challenges that may be different for each product that is placed in the market. However, GE has so far successfully sailed through all the challenges and developed a steep learning curve about BOP markets. However, it is now facing the challenge of ensuring sustainability of product pipeline. The company is also keen to exploit the opportunities for reverse innovation that super value products have provided. The company also wants to assess the disruptive impact of these products in domestic medical device markets as well as markets outside India.

  • Learning Objectives

    Learning Objectives

    To enable discussions on the potential opportunity that the BoP market has in the healthcare and strategies to exploit this opportunity. To understand the complexity involved in entering the BoP markets. To examine how reverse innovations can be a source of sustainable strategic advantage for MNCs.